Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 00:14 | 2025-11-13 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $1,010.50 | 1,000 | $1,010,500 | 2,840 | -26.0% |
| 2025-08-28 23:14 | 2025-08-28 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $734.93 | 1,000 | $734,930 | 3,840 | -20.7% |
| 2025-05-27 23:13 | 2025-05-27 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $716.41 | 1,000 | $716,410 | 4,840 | -17.1% |
| 2025-03-13 23:17 | 2025-03-13 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $818.24 | 1,000 | $818,240 | 5,840 | -14.6% |
| 2024-11-09 00:18 | 2024-11-08 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $803.38 | 900 | $723,042 | 5,480 | -14.1% |
| 2024-08-26 23:21 | 2024-08-26 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $950.00 | 750 | $712,500 | 6,380 | -10.5% |
| 2024-06-03 23:15 | 2024-06-03 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $819.47 | 750 | $614,603 | 7,130 | -9.5% |
| 2024-03-11 23:27 | 2024-03-11 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $753.60 | 750 | $565,200 | 7,880 | -8.7% |
| 2023-11-07 00:25 | 2023-11-06 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $571.10 | 670 | $382,637 | 4,708 | -12.5% |
| 2023-08-22 23:34 | 2023-08-21 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $546.51 | 600 | $327,906 | 5,378 | -10.0% |
| 2023-05-16 23:31 | 2023-05-15 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $435.29 | 600 | $261,174 | 5,978 | -9.1% |
| 2023-03-02 00:31 | 2023-02-27 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $322.47 | 600 | $193,482 | 6,578 | -8.4% |
| 2022-09-06 23:22 | 2022-09-01 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $301.00 | 1,000 | $301,000 | 5,274 | -15.9% |
| 2022-06-03 01:43 | 2022-06-01 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $313.44 | 1,000 | $313,440 | 6,274 | -13.7% |
| 2022-03-01 00:38 | 2022-02-25 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $243.84 | 1,660 | $404,774 | 7,274 | -18.6% |
| 2021-04-30 03:31 | 2021-04-28 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $181.38 | 3,000 | $544,140 | 5,987 | -33.4% |
| 2020-03-03 23:27 | 2020-03-02 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $128.00 | 3,700 | $473,600 | 4,740 | -43.8% |
| 2019-03-22 22:16 | 2019-03-22 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $128.50 | 1,000 | $128,500 | 4,595 | -17.9% |
| 2019-03-05 23:51 | 2019-03-01 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $127.01 | 1,000 | $127,010 | 5,595 | -15.2% |
| 2018-09-04 23:50 | 2018-09-04 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $105.57 | 600 | $63,342 | 3,530 | -14.5% |
| 2018-03-05 23:30 | 2018-03-01 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $76.50 | 860 | $65,790 | 1,637 | -34.4% |
| 2018-02-24 01:42 | 2018-02-21 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $77.55 | 876 | $67,934 | 2,472 | -26.2% |
| 2018-02-06 02:39 | 2018-02-05 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $81.09 | 900 | $72,981 | 4,130 | -17.9% |
| 2017-02-03 23:22 | 2017-02-02 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $77.52 | 2,000 | $155,040 | 886 | -69.3% |
| 2016-12-19 22:48 | 2016-12-16 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $72.13 | 1,000 | $72,130 | 300 | -76.9% |
| 2016-07-29 20:23 | 2016-07-28 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $83.16 | 1,213 | $100,873 | 1,300 | -48.3% |
| 2016-05-03 23:36 | 2016-04-29 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $75.86 | 1,600 | $121,368 | 2,513 | -38.9% |
| 2015-06-01 23:28 | 2015-05-29 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $78.33 | 200 | $15,666 | 3,846 | -4.9% |
| 2015-02-06 17:57 | 2015-02-05 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $71.03 | 374 | $26,565 | 4,046 | -8.5% |
| 2014-11-12 20:55 | 2014-11-11 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $68.49 | 750 | $51,368 | 3,047 | -19.8% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.